Michael J. Rossi

Insider Reports History

Entity
Individual
Location
230 Park Avenue, Suite 3350, New York, NY
Signature
/s/ John LaRocca, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael J. Rossi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mirion Technologies, Inc. Medical Group President Class A Common Stock 116K $1.21M $10.45 Nov 1, 2023 Direct
Mirion Technologies, Inc. Medical Group President Common Stock 80.4K $804K $10.00 Nov 1, 2022 Direct
Y-mAbs Therapeutics, Inc. PRESIDENT & CEO, Director Common Stock 137K $713K $5.20 Mar 7, 2025 Direct
Y-mAbs Therapeutics, Inc. PRESIDENT & CEO, Director Employee Stock Option (right to buy) 211K Jan 17, 2025 Direct

Insider Reports Filed by Michael J. Rossi

Symbol Company Period Transactions Value $ Form Type Date Filed Role
YMAB Y-mAbs Therapeutics, Inc. Mar 7, 2025 1 -$20.4K 4 Mar 11, 2025 PRESIDENT & CEO, Director
YMAB Y-mAbs Therapeutics, Inc. Jan 17, 2025 2 $0 4 Jan 22, 2025 PRESIDENT & CEO, Director
YMAB Y-mAbs Therapeutics, Inc. Feb 12, 2024 3 $0 4 Feb 14, 2024 PRESIDENT & CEO, Director
YMAB Y-mAbs Therapeutics, Inc. Nov 6, 2023 1 $0 4 Nov 8, 2023 President and CEO, Director
YMAB Y-mAbs Therapeutics, Inc. Nov 6, 2023 0 $0 3 Nov 8, 2023 President & CEO, Director
MIR Mirion Technologies, Inc. Nov 1, 2023 1 -$38.2K 4 Nov 3, 2023 Medical Group President
MIR Mirion Technologies, Inc. Mar 29, 2023 1 $0 4 Mar 31, 2023 Medical Group President
MIR Mirion Technologies, Inc. Nov 1, 2022 1 $0 4 Nov 3, 2022 Medical Group President
MIR Mirion Technologies, Inc. Oct 3, 2022 0 $0 3 Oct 6, 2022 Medical Group President